Good Life Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-468
| Closed | -$233K | – | 533 |
|
2025
Q1 | $233K | Buy |
468
+10
| +2% | +$4.97K | 0.02% | 446 |
|
2024
Q4 | $239K | Sell |
458
-163
| -26% | -$84.9K | 0.02% | 416 |
|
2024
Q3 | $384K | Buy |
621
+163
| +36% | +$101K | 0.02% | 404 |
|
2024
Q2 | $253K | Buy |
458
+7
| +2% | +$3.87K | 0.02% | 389 |
|
2024
Q1 | $262K | Buy |
451
+5
| +1% | +$2.91K | 0.02% | 376 |
|
2023
Q4 | $237K | Hold |
446
| – | – | 0.02% | 376 |
|
2023
Q3 | $226K | Buy |
446
+43
| +11% | +$21.8K | 0.03% | 361 |
|
2023
Q2 | $210K | Sell |
403
-30
| -7% | -$15.7K | 0.02% | 370 |
|
2023
Q1 | $250K | Sell |
433
-39
| -8% | -$22.5K | 0.03% | 327 |
|
2022
Q4 | $260K | Sell |
472
-105
| -18% | -$57.8K | 0.04% | 292 |
|
2022
Q3 | $293K | Buy |
577
+55
| +11% | +$27.9K | 0.04% | 256 |
|
2022
Q2 | $284K | Buy |
522
+52
| +11% | +$28.3K | 0.04% | 268 |
|
2022
Q1 | $278K | Hold |
470
| – | – | 0.03% | 300 |
|
2021
Q4 | $314K | Sell |
470
-34
| -7% | -$22.7K | 0.04% | 280 |
|
2021
Q3 | $288K | Sell |
504
-5
| -1% | -$2.86K | 0.04% | 275 |
|
2021
Q2 | $257K | Sell |
509
-27
| -5% | -$13.6K | 0.05% | 253 |
|
2021
Q1 | $243K | Buy |
536
+73
| +16% | +$33.1K | 0.05% | 252 |
|
2020
Q4 | $217K | Buy |
+463
| New | +$217K | 0.05% | 239 |
|